547 related articles for article (PubMed ID: 25795019)
1. Comparative reactivity of the myeloperoxidase-derived oxidants HOCl and HOSCN with low-density lipoprotein (LDL): Implications for foam cell formation in atherosclerosis.
Ismael FO; Proudfoot JM; Brown BE; van Reyk DM; Croft KD; Davies MJ; Hawkins CL
Arch Biochem Biophys; 2015 May; 573():40-51. PubMed ID: 25795019
[TBL] [Abstract][Full Text] [Related]
2. Myeloperoxidase-derived oxidants modify apolipoprotein A-I and generate dysfunctional high-density lipoproteins: comparison of hypothiocyanous acid (HOSCN) with hypochlorous acid (HOCl).
Hadfield KA; Pattison DI; Brown BE; Hou L; Rye KA; Davies MJ; Hawkins CL
Biochem J; 2013 Jan; 449(2):531-42. PubMed ID: 23088652
[TBL] [Abstract][Full Text] [Related]
3. Role of Myeloperoxidase Oxidants in the Modulation of Cellular Lysosomal Enzyme Function: A Contributing Factor to Macrophage Dysfunction in Atherosclerosis?
Ismael FO; Barrett TJ; Sheipouri D; Brown BE; Davies MJ; Hawkins CL
PLoS One; 2016; 11(12):e0168844. PubMed ID: 27997605
[TBL] [Abstract][Full Text] [Related]
4. Low-density lipoprotein modified by myeloperoxidase oxidants induces endothelial dysfunction.
Abdo AI; Rayner BS; van Reyk DM; Hawkins CL
Redox Biol; 2017 Oct; 13():623-632. PubMed ID: 28818791
[TBL] [Abstract][Full Text] [Related]
5. Comparative reactivity of the myeloperoxidase-derived oxidants hypochlorous acid and hypothiocyanous acid with human coronary artery endothelial cells.
Lloyd MM; Grima MA; Rayner BS; Hadfield KA; Davies MJ; Hawkins CL
Free Radic Biol Med; 2013 Dec; 65():1352-1362. PubMed ID: 24120969
[TBL] [Abstract][Full Text] [Related]
6. The role of the myeloperoxidase-derived oxidant hypothiocyanous acid (HOSCN) in the induction of mitochondrial dysfunction in macrophages.
Love DT; Guo C; Nikelshparg EI; Brazhe NA; Sosnovtseva O; Hawkins CL
Redox Biol; 2020 Sep; 36():101602. PubMed ID: 32570189
[TBL] [Abstract][Full Text] [Related]
7. Cellular targets of the myeloperoxidase-derived oxidant hypothiocyanous acid (HOSCN) and its role in the inhibition of glycolysis in macrophages.
Love DT; Barrett TJ; White MY; Cordwell SJ; Davies MJ; Hawkins CL
Free Radic Biol Med; 2016 May; 94():88-98. PubMed ID: 26898502
[TBL] [Abstract][Full Text] [Related]
8. Reactions and reactivity of myeloperoxidase-derived oxidants: differential biological effects of hypochlorous and hypothiocyanous acids.
Pattison DI; Davies MJ; Hawkins CL
Free Radic Res; 2012 Aug; 46(8):975-95. PubMed ID: 22348603
[TBL] [Abstract][Full Text] [Related]
9. Modification of low-density lipoprotein by myeloperoxidase-derived oxidants and reagent hypochlorous acid.
Malle E; Marsche G; Arnhold J; Davies MJ
Biochim Biophys Acta; 2006 Apr; 1761(4):392-415. PubMed ID: 16698314
[TBL] [Abstract][Full Text] [Related]
10. Secondary radicals derived from chloramines of apolipoprotein B-100 contribute to HOCl-induced lipid peroxidation of low-density lipoproteins.
Hazell LJ; Davies MJ; Stocker R
Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):489-95. PubMed ID: 10215584
[TBL] [Abstract][Full Text] [Related]
11. What are the plasma targets of the oxidant hypochlorous acid? A kinetic modeling approach.
Pattison DI; Hawkins CL; Davies MJ
Chem Res Toxicol; 2009 May; 22(5):807-17. PubMed ID: 19326902
[TBL] [Abstract][Full Text] [Related]
12. Proatherogenic modification of LDL by surface-bound myeloperoxidase.
Sokolov AV; Kostevich VA; Runova OL; Gorudko IV; Vasilyev VB; Cherenkevich SN; Panasenko OM
Chem Phys Lipids; 2014 May; 180():72-80. PubMed ID: 24631066
[TBL] [Abstract][Full Text] [Related]
13. Thiocyanate catalyzes myeloperoxidase-initiated lipid oxidation in LDL.
Exner M; Hermann M; Hofbauer R; Hartmann B; Kapiotis S; Gmeiner B
Free Radic Biol Med; 2004 Jul; 37(2):146-55. PubMed ID: 15203186
[TBL] [Abstract][Full Text] [Related]
14. Myeloperoxidase-derived oxidants inhibit sarco/endoplasmic reticulum Ca2+-ATPase activity and perturb Ca2+ homeostasis in human coronary artery endothelial cells.
Cook NL; Viola HM; Sharov VS; Hool LC; Schöneich C; Davies MJ
Free Radic Biol Med; 2012 Mar; 52(5):951-61. PubMed ID: 22214747
[TBL] [Abstract][Full Text] [Related]
15. Soluble RAGE blocks scavenger receptor CD36-mediated uptake of hypochlorite-modified low-density lipoprotein.
Marsche G; Weigle B; Sattler W; Malle E
FASEB J; 2007 Oct; 21(12):3075-82. PubMed ID: 17536039
[TBL] [Abstract][Full Text] [Related]
16. Role of thiocyanate in the modulation of myeloperoxidase-derived oxidant induced damage to macrophages.
Guo C; Davies MJ; Hawkins CL
Redox Biol; 2020 Sep; 36():101666. PubMed ID: 32781424
[TBL] [Abstract][Full Text] [Related]
17. A pivotal role for NF-κB in the macrophage inflammatory response to the myeloperoxidase oxidant hypothiocyanous acid.
Pan GJ; Rayner BS; Zhang Y; van Reyk DM; Hawkins CL
Arch Biochem Biophys; 2018 Mar; 642():23-30. PubMed ID: 29410057
[TBL] [Abstract][Full Text] [Related]
18. Tryptophan residues are targets in hypothiocyanous acid-mediated protein oxidation.
Hawkins CL; Pattison DI; Stanley NR; Davies MJ
Biochem J; 2008 Dec; 416(3):441-52. PubMed ID: 18652572
[TBL] [Abstract][Full Text] [Related]
19. Role of myeloperoxidase-derived oxidants in the induction of vascular smooth muscle cell damage.
Flouda K; Mercer J; Davies MJ; Hawkins CL
Free Radic Biol Med; 2021 Apr; 166():165-177. PubMed ID: 33631301
[TBL] [Abstract][Full Text] [Related]
20. High plasma thiocyanate levels modulate protein damage induced by myeloperoxidase and perturb measurement of 3-chlorotyrosine.
Talib J; Pattison DI; Harmer JA; Celermajer DS; Davies MJ
Free Radic Biol Med; 2012 Jul; 53(1):20-9. PubMed ID: 22609005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
